Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

UVM Vaccine Testing Center Highlighted for Participation in Zika Vaccine Trial

August 21, 2018 by Madi Wood

On Thursday, August 16, the National Institute of Allergy and Infectious Diseases (NIAID) announced that vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

Zika virus particles (red) shown in African green monkey kidney cells. (Image courtesy of NIAID)

On Thursday, August 16, the National Institute of Allergy and Infectious Diseases (NIAID) announced that vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg School of Public Health Center for Immunization Research in Baltimore, Md., and at the Vaccine Testing Center at the Larner College of Medicine at the University of Vermont in Burlington. NIAID is sponsoring the trail.

Read more on National Institutes of Health, United Press International Online.



Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Questions?

Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!